CVKD
NASDAQ · Pharmaceuticals
Cadrenal Therapeutics Inc
$0.98
-0.02 (-2.00%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,629.6% upside
Low Target
$12.65
Average Target
$16.95
High Target
$22.59
Current Price
$0.98
Current
$0.98
$0.98
Target
$16.95
$16.95
$12.65
$16.95 avg
$22.59
Scenario Analysis
Bear Case
$12.65
1,190.8%
Low target
Base Case
$16.95
+1,629.6%
Avg target
Bull Case
$22.59
+2,205.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$13.11
-92.5% from high
52-Week Low
$0.82
+20.1% from low
Target vs 52W High
$16.95
+29.3% vs high
Next Earnings Report
Nov 9, 2026
1d
tomorrow
EPS Est: $-0.93
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals